• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Cardiology

Synergistic interaction between risk burden and genetics for atrial fibrillation development

byRhianna DavisandAlex Chan
April 19, 2023
in Cardiology, Chronic Disease
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. In a large prospective study, risk burden and genetic predisposition acted synergistically to significantly increase the risk of developing atrial fibrillation. 

Evidence Rating Level: 2 (Good)

Atrial fibrillation (AF) is one of the most common cardiac arrhythmias and is associated with a high risk of thromboembolism and death. This study aims to identify the effects of both risk factor burden and genetic predisposition on the 10-year risk of developing atrial fibrillation. 352,804 participants aged 40-69 were enrolled in this study between 2006 and 2010 from the UK biobank. A polygenic risk score was calculated for each participant, using 165 known genetic risk markers for atrial fibrillation. Risk factor burden was determined by BMI, diabetes mellitus, alcohol use, smoking, blood pressure, and cardiac history (MI or CHF). Participants were divided into three age groups: 40-49, 50-59, and 60-69. A lower risk factor burden was significantly associated with a later onset of atrial fibrillation (p<0.001). In each age category, risk factor burden and genetic predisposition acted synergistically to significantly increase the AF risk (p <0.05). The greatest AF risk was found for those aged 60-69 with elevated risk factor profile and genetic predisposition (10-year risk 11.1%, 95% CI 10.72-11.49). In comparison, participants aged 60-69 with an elevated risk factor burden and low genetic predisposition had a 3.91% 10-year risk of developing AF (95% CI 3.68-4.14). Overall, this study demonstrates that risk burden and genetic predisposition act synergistically to increase the risk of developing AF. In the clinical setting, identifying younger individuals with a strong genetic predisposition for AF may be a beneficial preventative strategy, providing the opportunity for early intervention to reduce risk factor profile and 10-year AF risk.

Click to read the study in BMC Medicine

Image: PD

©2023 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

RELATED REPORTS

Steroidal mineralocorticoid receptor antagonists show little mortality benefit in patients receiving dialysis

Spironolactone does not reduce cardiovascular events in patients receiving maintenance dialysis

Artificial intelligence stethoscope detects heart disease in seconds

Tags: atrial fibrillationcardiologygenetics
Previous Post

Nivolumab plus ipilimumab does not improve survival in post-nephrectomy patients with renal cell carcinoma

Next Post

Over-the-scope clips superior to standard treatment of nonvariceal upper GI bleeding

RelatedReports

Nearly Half of All Pediatric Buprenorphine Exposures Result in Hospitalization
Cardiology

Steroidal mineralocorticoid receptor antagonists show little mortality benefit in patients receiving dialysis

September 18, 2025
Fish oil and aspirin did not reduce arteriovenous fistula failure: The FAVOURED trail
Cardiology

Spironolactone does not reduce cardiovascular events in patients receiving maintenance dialysis

September 17, 2025
Neurocognitive deficits in congenital heart disease may not worsen with age
AI Roundup

Artificial intelligence stethoscope detects heart disease in seconds

September 16, 2025
Long-term outcomes for off-pump and on-pump CABG are similar
Cardiology

Beta-Blocker Use and Health Status Among Patients With Heart Failure With Preserved Ejection Fraction

September 8, 2025
Next Post
Gastric bypass surgery reduces cardio-metabolic risk factors

Over-the-scope clips superior to standard treatment of nonvariceal upper GI bleeding

Renal stones in women linked with increased risk of coronary heart disease

Hydrochlorothiazide does not impact risk of kidney-stone recurrence

Algorithm improves pediatric chronic cough outcomes

Intranasal vaccine against Bordetella pertussis invokes seronegative IgA response

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Factors in the Initial Resuscitation of Patients With Severe Trauma: The FiiRST-2 Randomized Clinical Trial
  • Antioxidant Treatment and the Chance to Conceive in Men Seeking Fertility Care: The SUMMER Randomized Clinical Trial
  • DAWN Trial: Redefining the Treatment Window for Stroke Thrombectomy
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • AI News
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.